Correlation Between Neurocrine Biosciences and Intracellular
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Intracellular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Intracellular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Intracellular Th, you can compare the effects of market volatilities on Neurocrine Biosciences and Intracellular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Intracellular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Intracellular.
Diversification Opportunities for Neurocrine Biosciences and Intracellular
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Neurocrine and Intracellular is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Intracellular Th in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intracellular Th and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Intracellular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intracellular Th has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Intracellular go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Intracellular
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 1.15 times less return on investment than Intracellular. But when comparing it to its historical volatility, Neurocrine Biosciences is 1.27 times less risky than Intracellular. It trades about 0.19 of its potential returns per unit of risk. Intracellular Th is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 7,682 in Intracellular Th on August 28, 2024 and sell it today you would earn a total of 817.00 from holding Intracellular Th or generate 10.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurocrine Biosciences vs. Intracellular Th
Performance |
| Timeline |
| Neurocrine Biosciences |
| Intracellular Th |
Neurocrine Biosciences and Intracellular Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and Intracellular
The main advantage of trading using opposite Neurocrine Biosciences and Intracellular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Intracellular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intracellular will offset losses from the drop in Intracellular's long position.| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
| Intracellular vs. Alkermes Plc | Intracellular vs. Ironwood Pharmaceuticals | Intracellular vs. Pacira BioSciences, | Intracellular vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |